2007

1. Phase I and Pharmacokinetic Study of Gemcitabine Administered at Fixed-Dose Rate, Combined with Docetaxel/Melphalan/Carboplatin, with Autologous Hematopoietic Progenitor-Cell Support, in Patients with Advanced Refractory Tumors

   Biology of Blood and Marrow Transplantation, Vol. 13, Núm. 11, pp. 1324-1337